This study investigates glucose management in people with pancreatic cancer. The purpose of this study is to explore the feasibility of monitoring and managing glucose levels in individuals with this condition.
The study evaluates the impact of glucose management on pancreatic cancer. It focuses on understanding the relationship between glucose levels and the progression of the condition.
- Who can participate: Adults 18 years or older with pancreatic ductal adenocarcinoma can participate. Participants must have adequate bone marrow and organ function, and be fit for systemic therapy with FOLFIRINOX.
- Study details: Participants will have their glucose levels monitored using continuous glucose monitors. They may receive anti-hyperglycemic treatments such as metformin or insulin.
How understandable was the trial content above?
Hard to understand
Easy to understand